Biocryst Pharmaceuticals, Inc. · NASDAQ:BCRX

Menon Sandeep received 205,150 Biocryst Pharmaceuticals, Inc. shares as an award (Form 4)

Traded Apr 6, 2026 · Filed Apr 7, 2026

On Apr 6, 2026, Menon Sandeep (Chief R&D Officer) received 205,150 Biocryst Pharmaceuticals, Inc. shares as an award, leaving 205,150 shares. Filed Apr 7, 2026 (Form 4).

Awarded
205,150 shares
Holding after
205,150 shares
Trading plan
No
Role
Chief R&D Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 6, 2026Common StockAward205,150205,150Direct

Source

View original at SEC

Related